I. Introduction On 1 February 2002, the UK Office of Fair Trading (“OFT”) published its decision on the amended standard conditions for licensing the commercial exhibition of films (the “Amended Conditions”) notified by the Film Distributors' Association Ltd (“FDA”) . Following recommendations from the OFT, the FDA amended the version of the standard licensing conditions it originally submitted for clearance. The OFT found that the standard licensing conditions, as amended, did not impose restrictions on exhibitors that would have an appreciable effect on competition in the exhibition of films, and therefore did not infringe the Chapter I prohibition contained in the Competition Act 1998 (the “Act”). II. Notification On 15 August 2000, the FDA notified its standard licensing conditions,
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.